|
|
1.
|
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial. MedStar authors:
Year: 2016
Citation: - American Journal of Cardiovascular Drugs. 16(1):55-65, 2016 Feb.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Ballantyne CM, Barter PJ, Borgman M, Brewer HB, Herrman JP, Hu B, Kastelein JJ, Kataoka Y, Merkely B, Nicholls SJ, Nissen SE, Puri R, Uno K, Wolski K
|
|
|
2.
|
Utility of Multimodality Intravascular Imaging and the Local Hemodynamic Forces to Predict Atherosclerotic Disease Progression. MedStar authors:
Year: 2020
Citation: - Jacc: Cardiovascular Imaging. 13(4):1021-1032, 2020 04.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bourantas CV, Fotiadis DI, Garcia-Garcia HM, Heg D, Kalatzis F, Karagiannis A, Koskinas KC, Mathur A, Michalis LK, Naka KK, Papafaklis MI, Raber L, Radu MD, Sakellarios A, Serruys PW, Taniwaki M, Ueki Y, Windecker S, Yamaji K, Zanchin T
|
